Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 22, 2021

SELL
$81.94 - $135.34 $230,743 - $381,117
-2,816 Closed
0 $0
Q3 2020

Nov 10, 2020

BUY
$73.3 - $89.48 $206,412 - $251,975
2,816 New
2,816 $234,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $1.63B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Windmill Hill Asset Management LTD Portfolio

Follow Windmill Hill Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Windmill Hill Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Windmill Hill Asset Management LTD with notifications on news.